Articles tagged "Kidney/liver transplantation"

2019 American Transplant Congress
Allograft Quality Impacts Simultaneous Liver Kidney Transplant Survival Outcomes in Recipients That Undergo Liver Re-Transplantation
J. Reyes, M. Eerhart, C. Blanton, P. Chlebeck, E. Polyak, Y. Yankol, L. Fernandez
Department of Surgery, University of Wisconsin - Madison, Madison, WI
*Purpose: The only effective therapeutic strategy for irreversible liver graft failure is re-transplantation. The impact of liver and kidney quality in secondary SLK (sSLK) survival…
2019 American Transplant Congress
The Clinical & Economic Impact Of Allosensitization In Liver Alone And Simultaneous Liver Kidney Transplantation
M. Askar¹, G. Saracino¹, A. Elsabbagh², J. Fung³, T. Srinivas⁴, S. Flechner⁵, J. Trotter¹, G. Testa¹, B. Kaplan⁶, G. Klintmalm¹, J. Schold⁵, S. Asrani¹
¹Transplant Center, Baylor Scott & White, Dallas, TX, ²St. Vincent Health, Indianapolis, IN, ³University of Chicago Medicine, Chigao, IL, ⁴Intermountain Healthcare, Salt Lake City, UT, ⁵Cleveland Clinic, Cleveland, OH, ⁶Transplant Center, Baylor Scott & White, Temple, TX
*Purpose: Allosensitization is thought to have marginal impact among patients that undergo liver transplantation (LTA); further among simultaneous liver kidney transplantation (SLKT), livers may protect…
2019 American Transplant Congress
Staged Procedure In Simultaneous Liver And Kidney Transplant -the “Swedish” Experience
A. Gravetz
Transplant Surgery, Swedish Medical Center, Seattle, WA
*Purpose: As many as 30% of liver transplant candidates have renal insufficiency requiring a combined liver and kidney transplantation. The prolonged and complex simultaneous liver-kidney…
2019 American Transplant Congress
Intra-Operative Kinetics of Anti-HLA Antibodies in Simultaneous Liver-Kidney Transplantation
M. Kueht, P. Jindra, M. Cusick, N. Galvan, A. Rana, J. Goss
Baylor College of Medicine, Houston, TX
*Purpose: In simultaneous liver-kidney transplantation (SLKT) in highly-sensitized patients, donor specific anti-HLA antibodies (DSA) can be present prior to transplant leading to positive crossmatch, yet…
2019 American Transplant Congress
Donor-Derived Cell-Free DNA in Urine Identifies BKVN with Graft Injury in BK Viruria Kidney Transplant Recipients
G. Huang¹, X. Chen¹, S. Yang², W. Chen², P. Chen³, X. Hou⁴, T. Jiang⁵, H. Liu⁵, X. Li⁵, C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ³Department of clinical laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ⁴Guangzhou KingMed Center for Clinical Laboratory Co.,Ltd., Guangzhou, China, ⁵Research and Development, AlloDx Biotech Co.Ltd., Suzhou, China
*Purpose: BK Polyomavirus nephropathy (BKVN) is an important cause of dysfunction and failure of renal transplants. Elevated levels of donor-derived cell-free DNA (dd-cfDNA) in the…
2019 American Transplant Congress
Outcomes of En Bloc Simultaneous Liver-Kidney Transplantation Compared to the Traditional Technique
A. R. Cortez, T. C. Lee, A. Kassam, M. C. Morris, L. K. Winer, L. Sage Silski, M. C. Cuffy, T. S. Diwan, R. C. Quillin, S. A. Shah
University of Cincinnati, Cincinnati, OH
*Purpose: Simultaneous liver-kidney transplantation (SLKT) is indicated for patients with end-stage liver disease (ESLD) and concurrent renal insufficiency. En bloc SLKT has been reported as…
2019 American Transplant Congress
Bortezomib Attenuates the Progression of Epithelial to Mesenchymal Transition through Smurf1 Akt mTOR P70S6K Pathway in Rat Allograft Renal Interstitial Fibrosis Model
R. Tan, Z. Wang, S. Fei, Z. Han, J. Tao, X. Ju, M. Gu
No.300 Guangzhou Road of Nanjing, Nanjing, China
*Purpose: Our study was to detect the effects of Bortezomib and Smurf1 in the EMT and allograft renal interstitial fibrosis.*Methods: Biomarkers of EMT, as well…
2019 American Transplant Congress
Assessing Pressure to Donate among Potential Living Kidney Donors
D. R. Helfer¹, J. Stanton², E. A. King¹, A. K. Eno¹, J. M. Ruck¹, A. A. Shaffer¹, A. G. Thomas¹, M. M. Waldram¹, A. M. Cameron¹, J. Kahn¹, L. Erby¹, M. L. Henderson¹, D. L. Segev¹, J. M. Garonzik Wang¹
¹Johns Hopkins University, Baltimore, MD, ²East Carolina University, Greenville, NC
*Purpose: In the setting of ongoing methods to increase living donation, including novel methods that harness the power of social media, it is imperative that…
2019 American Transplant Congress
Incidence and Predictors of Post-Kidney Biopsy (KBx) Bleeding in Liver Transplant (LT) Candidates with Renal Dysfunction
H. M. Wadei¹, P. Abader¹, N. Aslam², T. Jarmi¹, A. P. Keaveny¹, K. Croome¹, D. D. Lee¹, C. Taner¹
¹Department of Transplant, Mayo Clinic, Jacksonville, FL, ²Department of Medicine, Division of Nephrology, Mayo Clinic, Jacksonville, FL
*Purpose: Pre-LT kidney biopsy is seldom performed in LT candidates with renal dysfunction and/or proteinuria partially due to the limited information regarding KBx bleeding. We…
2019 American Transplant Congress
Effects of Co-Morbidities on Kidney Transplantation Outcome in South Korea: A Nationwide-Population Based Study
M. Yu¹, S. Park², J. Moon², J. Jeong², J. Kim², Y. Kim², K. Han³, Y. Kim², H. Lee²
¹Hanyang University Guri Hospital, Guri, Korea, Republic of, ²Seoul National University Hospital, Seoul, Korea, Republic of, ³College of Medicine, Catholic University, Seoul, Korea, Republic of
*Purpose: Kidney transplantation (KT) has become the most effective treatment for end stage renal disease. Improvement of general medical care as well as immunosuppressive agents…